Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule.
The Food and Drug Administration (FDA) is issuing a final rule establishing additional criteria and procedures by which over-the- counter (OTC) conditions may become eligible for consideration in the OTC drug monograph system. The criteria and procedures address how OTC drugs initially marketed in the United States after the OTC drug review began in 1972, and OTC drugs without any U.S. marketing experience, can meet the statutory definition of marketing to a "material extent" and "for a material time" and become eligible. If found eligible, the condition would be evaluated for general recognition of safety and effectiveness in accordance with FDA's OTC drug monograph regulations. FDA is also changing the current OTC drug monograph procedures to streamline the process and provide additional information in the review.
D006801:Humans; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence* / Q000379:methods; D004366:Nonprescription Drugs / Q000145:classification*; D011356:Product Labeling / Q000331:legislation & jurisprudence / Q000379:methods; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
D004366:Nonprescription Drugs